International Journal of Immunology

Volume 3, Issue 3, June 2015

  • A Review on: Antibody Engineering for Development of Therapeutic Antibodies

    Gemechu Chala, Birhanu Hailu, Aynalem Mandefro

    Issue: Volume 3, Issue 3, June 2015
    Pages: 27-36
    Received: 27 March 2015
    Accepted: 25 April 2015
    Published: 8 May 2015
    Abstract: The development of hybridoma technology in 1975 by the two scientists, Kohler and Milstein, has opened a new era for production of specific antibodies in diagnosis, treatment and prevention of diseases both in animals and humans. Since then, many scientists have worked much in the field of antibody cloning and fragmentation technique to produce a v... Show More
  • Relationship Between ABO and Rhesus Blood Groups and Susceptibility to Asthma Within Sokoto Metropolis, Nigeria

    Moses Nnaemeka Alo, Ukpai Agwu Eze, Saidu Abdulhi Yaro, Bello Jubril, Nelson Nnanna Nwanoke

    Issue: Volume 3, Issue 3, June 2015
    Pages: 37-41
    Received: 25 May 2015
    Accepted: 1 June 2015
    Published: 16 June 2015
    Abstract: Asthma is the result of chronic inflammation of the airways which subsequently results in increased contractability of the surrounding smooth muscles. This among other factors leads to bouts of narrowing of the airway and the classic symptoms of wheezing. As at 2011, World Health Organisation (WHO) reported that approximately 235 million people wor... Show More
  • Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior

    Magdy Abdullah Sayedelahl, Naser Nagib Nasr, Mahmoud Hamed Akr, Dina Sayed Sheha, Tahany Mohamed Rabie

    Issue: Volume 3, Issue 3, June 2015
    Pages: 42-46
    Received: 8 June 2015
    Accepted: 18 June 2015
    Published: 2 July 2015
    Abstract: Background: A randomized single-blinded study including 50 patients with allergic rhinitis. Objective: To evaluate and compare the efficacy of subcutaneous versus sublingual immunotherapy in treatment of allergic rhinitis. Materials and methods: Patients divided into Group A: twenty patients received subcutaneous immunotherapy and group B: twenty p... Show More